Peter Garred
8Patents
2h-index
5Co-inventors
40Inventor score
Filing activity: Jun 9, 2010 → Aug 9, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9573984B2 | Chimeric inhibitor molecules of complement activation | Emerging Cross-Sectional Technologies | 5 | Active |
| US9815876B2 | Chimeric inhibitor molecules of complement activation | Emerging Cross-Sectional Technologies | 3 | Active |
| US9012154B2 | Ficolin-3 assay | Physics | 0 | Active |
| US11203622B2 | MASP isoforms as inhibitors of complement activation | Human Necessities | 0 | Active |
| US10294286B2 | Chimeric inhibitor molecules of complement activation | Emerging Cross-Sectional Technologies | 0 | Active |
| US11945848B2 | Chimeric inhibitor molecules of complement activation | Emerging Cross-Sectional Technologies | 0 | Active |
| US11453709B2 | Chimeric inhibitor molecules of complement activation | Emerging Cross-Sectional Technologies | 0 | Active |
| US10752661B2 | Chimeric inhibitor molecules of complement activation | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.